Jay Barth Net Worth & Insider Trades
Jay Barth - Chief Medical Officer, Amicus Therapeutics, Inc
What is Jay Barth's Net Worth?
The current estimated net worth of Amicus Therapeutics, Inc's Chief Medical Officer, Jay Barth, is estimated to be about $11.83M . Jay Barth owns about 163,224 units of Amicus Therapeutics, Inc common stock. In the last 6 years at Amicus Therapeutics, Inc, Jay Barth has sold an estimated value of $10.68M worth.
What is Jay Barth's Past Insider Trading?
Jay Barth's largest purchase order was 243,098 units , worth over $2.42M on July 9, 2020. Jay Barth's largest sale order was 243,098 units , worth over $3.87M on July 9, 2020. In total, Jay Barth has made about 40 transactions over 6 years of their time at Amicus Therapeutics, Inc. Jay Barth usually trades in January, with the busiest year in 2020. The most recent transaction was a sale order of 4,064 units , worth over $58.95K on October 2, 2020.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Jay Barth
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Jay Barth's Salary in 2020?
As Chief Medical Officer of Amicus Therapeutics, Inc, Jay Barth has a total base salary of $366,269 . Jay Barth received compensation valued at about $2,920,956 in 2020 after becoming Chief Medical Officer. The vast majority of their compensation came in the form of stock awards of $1,315,184 , other earnings, plans or compensations of $598,197 , other compensation of $641,306 .
What is Jay Barth's' Mailing Address?
- Mailing address is C/o Amicus Therapeutics, Inc. 1 Cedar Brook Drive Cranbury NJ 08512 NJ
Amicus Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Change in Pension Value
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| John F. Crowley | 2020 | $719,514 | $514,800 | $5,479,971 | $2,492,491 | $1,282,843 | $825,505 | $11,315,124 |
| John F. Crowley | 2019 | $656,770 | $476,815 | $5,327,948 | $2,334,850 | $234,775 | $821,505 | $9,852,663 |
| John F. Crowley | 2018 | $637,640 | $445,710 | $3,861,699 | $1,654,347 | - | $820,567 | $7,419,963 |
| Daphne Quimi | 2020 | $45 | $228,712 | $1,534,382 | $697,894 | - | $34,639 | $2,947, |
| Daphne Quimi | 2019 | $400,000 | $212,960 | $1,311,492 | $538,808 | - | $17,487 | $2,480,747 |
| Daphne Quimi | 2018 | - | - | - | - | - | - | - |
| Bradley L. Campbell | 2020 | $515, | $368,872 | $2,557,304 | $1,163,159 | - | $33,694 | $4, |
| Bradley L. Campbell | 2019 | $500,877 | $378,788 | $2,254,114 | $987,822 | - | $19,538 | $4,141,139 |
| Bradley L. Campbell | 2018 | $468,109 | $327,209 | $1,411,802 | $604,817 | - | $16,710 | $2,828,646 |
| Hung Do | 2020 | $42 | $187,908 | $1,461,322 | $664,660 | - | $31,248 | $2,772,106 |
| Hung Do | 2019 | $414,625 | $200,678 | $1,393,462 | $574,732 | - | $22,129 | $2,605,626 |
| Hung Do | 2018 | - | - | - | - | - | - | - |
| Ellen S. Rosenberg | 2020 | $452, | $199,051 | $1,461,322 | $664,660 | $87,751 | $20,748 | $2,885,820 |
| Ellen S. Rosenberg | 2019 | $439,213 | $233,837 | $1,393,462 | $610,648 | - | $13,538 | $2,690,698 |
| Ellen S. Rosenberg | 2018 | $426,420 | $208,647 | $996,591 | $426,933 | - | $18,270 | $2,076,862 |
| Jay Barth | 2020 | $366,269 | - | $1,315,184 | $598,197 | - | $641,306 | $2,920,956 |
| Jay Barth | 2019 | $471,621 | $228,265 | $1,229,522 | $538,808 | - | $15,998 | $2,484,214 |
| Jay Barth | 2018 | $457,885 | $192,037 | $996,591 | $426,933 | - | $18,790 | $2,092,236 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1178879/000114036121014545/nc10021408x1_def14a.htm
What are Amicus Therapeutics, Inc's Past Insider Trades?
Amicus Therapeutics, Inc's most recent insider trade came on November 17, 2023 by John Crowley who sold 6,043 units worth $65.5K . In the last 16 years, insiders at Amicus Therapeutics, Inc have sold an estimated value of $190.23M and bought an estimated value of $193.86M worth of shares. Insider trading is most common in June, with the busiest year in 2008. The most active traders at the company are John Crowley, Executive Chairman, Bradley Campbell, President and CEO, and Daphne Quimi, Chief Financial Officer .
AMICUS THERAPEUTICS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||